Literature DB >> 15630218

Antioxidant activity and hypoglycemic effect of ferulic acid in STZ-induced diabetic mice and KK-Ay mice.

M Ohnishi1, T Matuo, T Tsuno, A Hosoda, E Nomura, H Taniguchi, H Sasaki, H Morishita.   

Abstract

Antioxidant activity and biological properties of ferulic acid (FA) are well recognized. This study was designed to estimate the potential utility of FA administered orally at low dosage for improvement of hyperglycemia in diabetes. With this aim we have evaluated the hypoglycemic effect of FA in two type diabetic animal models: (1) streptozotocin (STZ)-induced diabetic mice, a model of insulin-dependent diabetes mellitus (IDDM); (2) KK-Ay mice, a model of non-insulin dependent diabetes mellitus (NIDDM). In addition, we measured the production of thiobarbituric acid-reactive substances (TBARS) in brown adipose tissues of diabetic mice at the end of FA feeding experiment. FA at 0.01% and 0.1% of basal diet showed to suppress significantly blood glucose levels in STZ-induced diabetic mice. In KK-Ay mice 0.05% FA suppressed effectively blood glucose levels. In addition, FA inhibited the lipid peroxidation in brown adipose tissue of diabetic mice. Taken together, these findings suggest that dietary FA may be useful in alleviating oxidative stress and attenuating the hyperglycemic response associated with diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15630218     DOI: 10.1002/biof.552210161

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  26 in total

1.  Whole Grains in Amelioration of Metabolic Derangements.

Authors:  Samir Develaraja; Anup Reddy; Mukesh Yadav; Shalini Jain; Hariom Yadav
Journal:  J Nutrit Health Food Sci       Date:  2016-10-24

2.  Treatment with ferulic acid to rats with streptozotocin-induced diabetes: effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic β cell.

Authors:  Souvik Roy; Satyajit Kumar Metya; Santanu Sannigrahi; Noorjaman Rahaman; Faiqa Ahmed
Journal:  Endocrine       Date:  2013-01-09       Impact factor: 3.633

Review 3.  Antidiabetic phytoconstituents and their mode of action on metabolic pathways.

Authors:  Sudhanshu Kumar Bharti; Supriya Krishnan; Ashwini Kumar; Awanish Kumar
Journal:  Ther Adv Endocrinol Metab       Date:  2018-02-12       Impact factor: 3.565

Review 4.  Mechanism of action of natural products used in the treatment of diabetes mellitus.

Authors:  Pranav Kumar Prabhakar; Mukesh Doble
Journal:  Chin J Integr Med       Date:  2011-08-09       Impact factor: 1.978

5.  Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes.

Authors:  Ran Choi; Bo Hwan Kim; Jarinyaporn Naowaboot; Mi Young Lee; Mi Ri Hyun; Eun Ju Cho; Eun Soo Lee; Eun Young Lee; Young Chul Yang; Choon Hee Chung
Journal:  Exp Mol Med       Date:  2011-12-31       Impact factor: 8.718

6.  Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-A(y) mice.

Authors:  Kunihisa Iwai
Journal:  Plant Foods Hum Nutr       Date:  2008-12       Impact factor: 3.921

7.  Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.

Authors:  Ricardo Valladares; Dhyana Sankar; Nan Li; Emily Williams; Kin-Kwan Lai; Asmaa Sayed Abdelgeliel; Claudio F Gonzalez; Clive H Wasserfall; Joseph Larkin; Desmond Schatz; Mark A Atkinson; Eric W Triplett; Josef Neu; Graciela L Lorca
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

8.  Ferulic acid ameliorates chronic constriction injury induced painful neuropathy in rats.

Authors:  Manoj Aswar; Vijay Patil
Journal:  Inflammopharmacology       Date:  2016-07-02       Impact factor: 4.473

9.  Ferulic Acid, an Angelica sinensis-Derived Polyphenol, Slows the Progression of Membranous Nephropathy in a Mouse Model.

Authors:  Chao-Wen Cheng; Wen-Liang Chang; Li-Cheng Chang; Chia-Chao Wu; Yuh-Feng Lin; Jin-Shuen Chen
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-11       Impact factor: 2.629

10.  Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters.

Authors:  Jasmine Bhathena; Christopher Martoni; Arun Kulamarva; Catherine Tomaro-Duchesneau; Meenakshi Malhotra; Arghya Paul; Aleksandra Malgorzata Urbanska; Satya Prakash
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.